No abstract available
Keywords:
Circulating tumor cells; EGFR mutation; Gefitinib; Meningeal metastasis; Osimertinib.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acrylamides / therapeutic use
-
Adenocarcinoma of Lung / cerebrospinal fluid
-
Adenocarcinoma of Lung / drug therapy
-
Adenocarcinoma of Lung / genetics
-
Adenocarcinoma of Lung / pathology*
-
Aniline Compounds / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Biomarkers, Tumor / cerebrospinal fluid*
-
Drug Resistance, Neoplasm*
-
ErbB Receptors / genetics
-
Female
-
Humans
-
Lung Neoplasms / cerebrospinal fluid
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / genetics
-
Lung Neoplasms / pathology*
-
Meningeal Carcinomatosis / cerebrospinal fluid
-
Meningeal Carcinomatosis / drug therapy
-
Meningeal Carcinomatosis / genetics
-
Meningeal Carcinomatosis / secondary*
-
Middle Aged
-
Mutation*
-
Prognosis
Substances
-
Acrylamides
-
Aniline Compounds
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
osimertinib
-
EGFR protein, human
-
ErbB Receptors